Search
Tirzepatide Treatment Options in Jacksonville, FL
A collection of 18 research studies where Tirzepatide is the interventional treatment. These studies are located in the Jacksonville, FL. Tirzepatide is used for conditions such as Obesity, Overweight and Type 2 Diabetes.
13 - 18 of 18
Featured Therapy
Unique Treatment for High Blood Pressure
Worried about high blood pressure? Think beyond typical high blood pressure treatments.
People who may be candidates for this procedure:
β’ Are at least 18 years old
β’ Have been unable to manage their high blood pressure with medications or lifestyle changes aloneΒΉ
Learn about a safe and effective procedure that may help reduce high blood pressure. See if you qualify today.
ΒΉ Kandzari DE, et al. J Am Coll Cardiol. Nov 7, 2023;82(19):1809-1823.
People who may be candidates for this procedure:
β’ Are at least 18 years old
β’ Have been unable to manage their high blood pressure with medications or lifestyle changes aloneΒΉ
Learn about a safe and effective procedure that may help reduce high blood pressure. See if you qualify today.
ΒΉ Kandzari DE, et al. J Am Coll Cardiol. Nov 7, 2023;82(19):1809-1823.
Conditions:
High Blood Pressure
High Blood Pressure (& [Essential Hypertension])
High Blood Pressure (Hypertension).
Hypertension
Essential Hypertension
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Conditions:
Healthy
Healthy Volunteer Study
Featured Offer
Discover Affordable Semaglutide Providers
We Checked the Checkout Page on Every Semaglutide Provider. Here's What We Found.
There's a big difference between the price on a landing page and what you actually pay. We went all the way through checkout so you know exactly what to expect.
π 5 providers ranked by true monthly cost
π΅ Options starting as low as $149/month
π₯ Only licensed providers using FDA-registered pharmacies
β Real Trustpilot scores included β including the ones with mixed reviews
π Includes cancellation policy warnings so you don't get stuck
There's a big difference between the price on a landing page and what you actually pay. We went all the way through checkout so you know exactly what to expect.
π 5 providers ranked by true monthly cost
π΅ Options starting as low as $149/month
π₯ Only licensed providers using FDA-registered pharmacies
β Real Trustpilot scores included β including the ones with mixed reviews
π Includes cancellation policy warnings so you don't get stuck
Conditions:
Weight Loss
Morbid Obesity
Featured Offer
Discover The Best Tirzepatide Providers
Finding legit tirzepatide online shouldn't feel like a gamble β but with hundreds of providers out there, it often does. We ranked the top 10 so you don't have to.
β Providers starting at $242/month
β Only accredited, licensed compounding pharmacies
β Ranked by real pricing, not marketing promises
β Includes patient reviews & hidden fee warnings
β Updated for 2026
β Providers starting at $242/month
β Only accredited, licensed compounding pharmacies
β Ranked by real pricing, not marketing promises
β Includes patient reviews & hidden fee warnings
β Updated for 2026
Conditions:
Overweight
Overweight and Obesity
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
Completed
The purpose of this study is to see if the study drug, tirzepatide administered once weekly, is safe and effective as a treatment for Nonalcoholic Steatohepatitis (NASH).
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
01/22/2025
Locations: Excel Medical Clinical Trials, Boca Raton, Florida +9 locations
Conditions: Nonalcoholic Steatohepatitis
Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese
Not Yet Recruiting
A phase 2 study to assess the efficacy of NA-931 alone or in addition to Tirzepatide to assess efficacy and safety in overweight or obese men and women
Gender:
ALL
Ages:
Between 19 years and 80 years
Trial Updated:
12/12/2024
Locations: Biomed Research Unit # 33012-104, Hialeah, Florida +2 locations
Conditions: Obesity and Overweight
A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)
Completed
The main purpose of this study is to investigate the effects of switching from glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy to tirzepatide glucose-dependent insulinotropic polypeptide (GIP) GLP-1 RA agonist in participants with type 2 diabetes (T2D).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/10/2024
Locations: Velocity Clinical Research, Hallandale Beach, Hallandale Beach, Florida +3 locations
Conditions: Type 2 Diabetes, Diabetes Mellitus, Type 2
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss
Completed
This was a study of tirzepatide in participants with obesity or overweight. The main purpose was to learn more about how tirzepatide maintained body weight loss. The study had two phases: a lead-in phase in which all participants took tirzepatide and a treatment phase in which participants either continued tirzepatide or switched to placebo. The study lasted about 2 years (25 visits).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/21/2024
Locations: Care Partners Clinical Research, Jacksonville, Florida +3 locations
Conditions: Obesity, Overweight
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
Completed
The purpose of this study is to compare the effect of the study drug tirzepatide to insulin degludec on blood sugar levels in participants with type 2 diabetes. The study will last about 67 weeks and may include up to 22 visits.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/14/2022
Locations: Indago Research & Health Center, Inc., Hialeah, Florida +3 locations
Conditions: Type 2 Diabetes Mellitus
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus
Completed
The purpose of this study is to evaluate the efficacy of the study drug tirzepatide in participants with type 2 diabetes mellitus.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
07/31/2019
Locations: Clinical Research of South Florida, Coral Gables, Florida +5 locations
Conditions: Type 2 Diabetes Mellitus
13 - 18 of 18
